Intraperitoneal Bioavailability

Intraperitoneal Bioavailability is the fraction of an administered drug that reaches the systemic circulation via the intraperitoneal route, distinguished from other routes by its specific absorption dynamics across the peritoneal membrane.

291

Publications

12.4K

Citations

1.5K

Authors

494

Institutions

Publications per year

2017–2026

50

Publications

291

1–5 of 291

Authors

1.5K

  1. PH
    Paul H. Sugarbaker

    MedStar Washington Hospital Center, United States

    5 publications · 342 citations

    5

    h-index

  2. OA
    O. Anthony Stuart

    MedStar Washington Hospital Center, United States

    4 publications · 269 citations

    4

    h-index

  3. WC
    Wim Ceelen

    Ghent University Hospital, Belgium

    4 publications · 187 citations

    4

    h-index

  4. DS
    Diego Segre

    University of Illinois Urbana-Champaign, United States

    3 publications · 80 citations

    3

    h-index

  5. AR
    Abbas Rahdar

    Zabol University, Iran

    3 publications · 75 citations

    3

    h-index

1–5 of 1.5K

Venues

  1. PubMed

    Repository · 17 publications · 1.3K citations

    14

    h-index

  2. Cancer Chemotherapy and Pharmacology

    13 publications · 650 citations

    12

    h-index

  3. Journal of Medicinal Chemistry

    11 publications · 480 citations

    11

    h-index

  4. Peritoneal Dialysis International

    PDI · 9 publications · 163 citations

    9

    h-index

  5. Journal of Pharmacy and Pharmacology

    JPP · 8 publications · 243 citations

    8

    h-index

1–5